Bas P.L. Wijnhoven
Multimodal treatment for GE junction cancer
Erasmus University Medical Center Rotterdam, Netherlands
CV
Joo Ha Hwang
Global efforts for primary and secondary prevention of gastric cancer
Stanford University School of Medicine, USA
CV
Yanbing Zhou
Prehabilitation for gastric cancer surgery
Affiliated Hospital of Qingdao University, China
CV
Mi Ran Jung
Efficacy of prophylactic abdominal drainage: Is it necessary?
Chonnam National University, Korea
CV
Ji-Hyeon Park
Nutritional optimization in gastric cancer surgery: Integrating evidence into ERAS protocols
The Catholic University of Korea, Korea
CV
Ho-Jin Lee
Actual practices and future direction of ERAS in gastric cancer surgery
Seoul National University, Korea
CV
Tae-Min Kim
Spatially resolved transcriptomic landscape of gastric cancers
The Catholic University of Korea, Korea
CV
Xiangdong Cheng
Perioperative tislelizumab plus chemotherapy for tsMHC-II–stratified locally advanced gastric or gastroesophageal junction cancer: A biomarker-stratified randomized phase 2 trial
Zhejiang Cancer Hospital, Chinese Academy of Sciences, China
CV
Minkyu Jung
Circulating tumor DNA: Implication of ctDNA in GC for adjuvant setting
Yonsei University, Korea
CV
Mitsuro Kanda
Emerging treatment option for gastric cancer using antisense oligonucleotide
Nagoya University Graduate School of Medicine, Japan
CV
Younghoon Kim
Recent update of pathologic and molecular diagnosis of GIST
The Catholic University of Korea, Korea
CV
Toshirou Nishida
Recent update of treatment using targeted agents in GIST
National Cancer Center Hospital, Japan
CV
Sebastian Bauer
Emerging role of circulating tumor DNA (ctDNA) in gastrointestinal stromal tumors (GIST)
West German Cancer Center, University Hospital Essen, Germany
CV
Dianqin Sun
Triangulating multi-level evidence on gastric cancer prevention
Erasmus University Medical Center, Netherlands
CV
Mee Soo Chang
Epstein-Barr virus-associated gastric carcinoma: Characteristics, pathogenesis, and emerging prospects
Seoul Clinical Laboratories, Korea
CV
Hye Seung Lee
Pathologic and therapeutic aspects of microsatellite unstable gastric cancer
Seoul National University, Korea
CV
Takeshi Kuwata
Genomically stable tumors with CLDN18.2
National Cancer Center Hospital East, Japan
CV
Sanghoon Ahn
Comparison of short-term outcomes between double-tract reconstruction and double-flap technique
Sungkyunkwan University, Korea
CV
Souya Nunobe
Clinical characteristics and surgical management of remnant gastric cancer after proximal gastrectomy
Cancer Institute Hospital Ariake, Japan
CV
Do Joong Park
Proximal gastrectomy for locally advanced gastric cancer
Seoul National University, Korea
CV
Hye Sook Han
Still standing strong: Cytotoxic chemotherapy in gastric cancer
Chungbuk National University, Korea
CV
Tania Fleitas-Kanonnikoff
Immunotherapies for gastric cancer: Insights into tumor immune microenvironment and latest ICI studies
University Hospital of Valencia, Spain
CV
Tadayoshi Hashimoto
ctDNA-guided MRD assessment in gastric cancer
National Cancer Center Hospital East, Japan
CV
Chen Li
Perioperative camrelizumab and rivoceranib plus chemo versus chemo for locally advanced gastric cancer
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China
CV
Hyung-Don Kim
Overall survival benefits from neoadjuvant DOS in locally advanced gastric cancer
University of Ulsan, Korea
CV
Bo Wei
Efficacy of laparoscopic gastrectomy after neoadjuvant ICI
Chinese PLA General Hospital, China
CV
Bas P.L. Wijnhoven
Scope and policy of prestigious journals: Insights from The British Journal of Surgery
Erasmus University Medical Center Rotterdam, Netherlands
CV
Han Ah Lee
Quality management of review process in high impact journals
Chung-Ang University, Korea
CV
Paul Baas
Journals on single organ malignancies: Still actual in a multidisciplinary scientific world?
Netherlands Cancer Institute, Netherlands
CV
Han Hong Lee
Future development strategies for The Journal of Gastric Cancer
The Catholic University of Korea, Korea
CV
Donghoon Kang
Cutting-edge endoscopic management for post-gastrectomy complication
The Catholic University of Korea, Korea
CV
Se Woo Park
EUS-guided Entero-enterostomy: Current landscape, recent advances, and future perspectives
Hallym University, Korea
CV
Noriya Uedo
No-touch endoscopic full-thickness resection with reopenable clip over-the-line method for gastric gastrointestinal stromal tumors
Osaka International Cancer Institute, Japan
CV
Ji-Ho Park
New minimally invasive approaches for gastric tumors: LECS and sentinel LN navigation surgery
Gyeongsang National University, Korea
CV
Hyunjung Lee
Tips for patient education before and after gastric cancer surgery
Samsung Medical Center, Korea
CV
A Ram Hong
Perioperative blood glucose management for patients with diabetes
Chonnam National University, Korea
CV
Dong-Seok Han
Practical implementation of enteral nutrition in gastric cancer patients
Seoul National University, Korea
CVLuncheon Symposium 1
Astellas
Hye Sook Han
Zolbetuximab in first-line palliative therapy for gastric cancer: Current evidence and clinical perspectives
Chungbuk National University, Korea
CVLuncheon Symposium 2
Johnson & Johnson MedTech
Jae Hun Chung
Close TIGHT with SLR: Staple line reinforcement for leak-free gastric cancer surgery
Pusan National University, Korea
CVLuncheon Symposium 3
Medtronic
Beom Su Kim
Laparoscopic para-aortic and hepatoduodenal (LN 12b, 12p) lymph node sampling, along with mesenteric division and large vessel ligation using Signia™ stapling
University of Ulsan, Korea
CVLuncheon Symposium 4
Daewoong
Da Hyun Jung
Leading beyond GERD & Gastritis_Clinical update
Yonsei University, Korea
CVSatellite Symposium 1
ONO/BMS
Minsu Kang
Exploring patient benefit through the advancement of gastric cancer therapy with Nivolumab
Seoul National University, Korea
CV